Drug
Dabigatran clinical trials
Also written Pradaxa and BIBR 1048 MS.
- studies test it
- 149
- open now
- 6
- in phase 3
- 27
- first study started
- 1998
Keep track of what changes. Save the Dabigatran studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
149 studies that test it; most in 2014 (12)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 1999 | 3 |
| 2000 | 2 |
| 2001 | 2 |
| 2002 | 4 |
| 2003 | 3 |
| 2004 | 5 |
| 2005 | 4 |
| 2006 | 6 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 7 |
| 2010 | 4 |
| 2011 | 9 |
| 2012 | 9 |
| 2013 | 11 |
| 2014 | 12 |
| 2015 | 7 |
| 2016 | 11 |
| 2017 | 8 |
| 2018 | 5 |
| 2019 | 5 |
| 2020 | 6 |
| 2021 | 4 |
| 2022 | 7 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 58
- Phase 2
- 22
- Phase 3
- 27
- Phase 4
- 35
- No phase
- 8
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 80 · Other 69
Boehringer Ingelheim (64) · Pfizer (5) · The University of Hong Kong (2) · Vanderbilt University Medical Center (2) · Imperial College London (2) · Bayer (2) · University of Sao Paulo General Hospital (2) · University of Alberta (2)
Often tested with
Tested in the same studies.
Rivaroxaban (21) · Apixaban (13) · Edoxaban (8) · Warfarin (7) · Rosuvastatin (5) · Pantoprazole (5) · Midazolam (4) · Enoxaparin (3)
Studies
Open first, then newest update. How each study uses Dabigatran is read from its arms, and is right about nine times in ten.
Testing it · 149
- Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus BacteremiaRecruitingPhase 4McGill University Health Centre/Research Institute of the McGill University Health CentreNCT06650501Written as Dabigatran
- THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)RecruitingPhase 4Imperial College LondonNCT05735639Written as Dabigatran Etexilate
- Compare the Efficacy and Safety of Dabigatran and Enoxaparin in Patients With Portal Vein Thrombosis With CirrhosisNot yet recruitingPhase 2/3Institute of Liver and Biliary Sciences, IndiaNCT06818279Written as Dabigatran
- Dabigatran Versus Rivaroxaban in Cerebral Venous ThrombosisRecruitingPhase 3Kafrelsheikh UniversityNCT06551402Written as Dabigatran Etexilate 150mg
- Bioequivalence Study of Dabigatran Etexilate Capsules 150 mg in Healthy Thai Volunteers Under Fasting ConditionsNot yet recruitingPhase 1International Bio serviceNCT06441916Written as Dabigatran Etexilate Capsules 150 mg
- MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke PreventionRecruitingPhase 3University of ZurichNCT03961334Written as Dabigatran
- A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female ParticipantsCompletedPhase 1PfizerNCT07190430Written as Dabigatran Etexilate
- Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial FibrillationCompletedPhase 4Intermountain Health Care, Inc.NCT03061006Written as Dabigatran Etexilate
- Dabigatran for Mitral Stenosis Atrial FibrillationActive, not recruitingPhase 4The University of Hong KongNCT04045093Written as Dabigatran etexilate
- Bioequivalence Study of Two Dabigatran Etexilate Mesylate Capsules in Healthy SubjectsCompletedPhase 1The Affiliated Hospital Of Guizhou Medical UniversityNCT06876623Written as dabigatran etexilate mesylate capsules 150mg
- Efficacy of Short Term Dabigatran Etexilate Followed by Aspirin Monotherapy After LAA (Left Atrial Appendage) Device Closure (the DEA-LAA Study).CompletedPhase 4Vanderbilt University Medical CenterNCT03539055Written as Dabigatran Etexilate Oral Capsule
- A Novel Therapeutic Target for Alzheimer's Disease in Men and Women 50-85 Years of Age.WithdrawnPhase 1University of Rhode IslandNCT03752294Written as Dabigatran
- The Nordic Aortic Valve Intervention Trial 4 (NOTION-4)Active, not recruitingNot applicableRigshospitalet, DenmarkNCT06449469Written as Dabigatran
- Evaluation of the Potential Drug-drug Interactions Between Gemfibrozil or Dabigatran Etexilate and CamlipixantCompletedPhase 1Bellus Health Inc. - a GSK companyNCT05959447Written as Dabigatran etexilate
- Safety and Tolerability of Dabigatran Etexilate in AdolescentsCompletedPhase 2Boehringer IngelheimNCT00844415Written as dabigatran etexilate
- A Pharmacokinetic Interaction Study Between Odalasvir, Given as a Single Agent or in Combination With Simeprevir, and Dabigatran Etexilate Mesylate in Healthy ParticipantsCompletedPhase 1Janssen Research & Development, LLCNCT02945020Written as Dabigatran etexilate mesylate
- PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial FibrillationCompletedPhase 3Imperial College LondonNCT03996772Written as Dabigatran
- A Study to Understand the Effect of a Study Medicine Called ARV-471 on Dabigatran Etexilate in Healthy AdultsCompletedPhase 1PfizerNCT05673889Written as Dabigatran etexilate
- Dabigatran Versus Apixaban in Cerebral Venous ThrombosisStatus unknownPhase 3Kafrelsheikh UniversityNCT06551415Written as Dabigatran Etexilate 150mg
- A Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy ParticipantsCompletedPhase 1BayerNCT06329895Written as Dabigatran etexilate
See all 149 studies that test Dabigatran →
Given in every arm · 18 — Dabigatran is usual care beside what is tested
- Evaluate the Effect of Vimseltinib on P-glycoprotein (P-gp) Inhibition in Healthy Male ParticipantsRecruitingPhase 1Deciphera Pharmaceuticals, LLCNCT07744802Written as Dabigatran
- Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCIRecruitingPhase 4Medical University of GdanskNCT04695106Written as Dabigatran Etexilate
- Phase 1 Study on Bioavailability, Food Effect, and Drug-Drug Interaction of ALG-097558 Tablets in Healthy VolunteersCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT06945276Written as Dabigatran
- A Study to Learn More About How Safe Nurandociguat is and How it Affects the Way the Body Processes Rosuvastatin and Dabigatran in Healthy AdultsWithdrawnPhase 1BayerNCT07515339Written as Dabigatran etexilate
- A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy SubjectsCompletedPhase 1Lumosa Therapeutics Co., Ltd.NCT04809818Written as Dabigatran
- A Study in Healthy Men to Test Whether Zongertinib Influences the Amount of 4 Other Medicines (Dabigatran, Rosuvastatin, Metformin, and Furosemide) in the BloodCompletedPhase 1Boehringer IngelheimNCT06504862Written as Dabigatran-etexilate
- The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial FibrillationActive, not recruitingPhase 4Herlev and Gentofte HospitalNCT03129490Written as Dabigatran Etexilate Oral Capsule
- The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)Active, not recruitingPhase 4Herlev and Gentofte HospitalNCT03129555Written as Dabigatran Etexilate Oral Capsule
- A Study of Darunavir in Combination With Cobicistat or Ritonavir, and Dabigatran Etexilate in Healthy ParticipantsCompletedPhase 1Janssen Research & Development, LLCNCT04208061Written as Dabigatran Etexilate
- Effect of Tepotinib on the PK of the P-gp Substrate Dabigatran EtexilateCompletedPhase 1Merck KGaA, Darmstadt, GermanyNCT03492437Written as Dabigatran Etexilate
- Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin in Participants With Renal Insufficiency in the Presence and Absence of Rifampin (MK-0000-386)CompletedPhase 1Merck Sharp & Dohme LLCNCT03311841Written as Dabigatran and pitavastatin oral solution
- BIBR 953 ZW in Healthy Elderly SubjectsCompletedPhase 1Boehringer IngelheimNCT02173730Written as BIBR 1048 MS
- Relative Bioavailability and Pharmacodynamics of Dabigatran With Enoxaparin in Healthy Male and Female VolunteersCompletedPhase 1Boehringer IngelheimNCT02171559Written as Dabigatran etexilate capsules
- Bioavailability of Dabigatran With or Without Clarithromycin in Healthy VolunteersCompletedPhase 1Boehringer IngelheimNCT02171585Written as Dabigatran etexilate
- Relative Bioavailability of Single Oral Doses of Dabigatran Etexilate With or Without Oral Administration of Verapamil in Two Different Dosages in Healthy Male and Female VolunteersCompletedPhase 1Boehringer IngelheimNCT02171533Written as dabigatran
- Bioavailability of BIBR 953 ZW After Dose of BIBR 1048 MSCompletedPhase 1Boehringer IngelheimNCT02170792Written as BIBR 1048 MS
- Bioavailability of BIBR 1048 MS With and Without Pantoprazole Under Influence of Food in Healthy SubjectsCompletedPhase 1Boehringer IngelheimNCT02170610Written as BIBR 1048 MS
- Bioavailability of BIBR 1048 MS Single Doses With or Without Pantoprazole in Healthy SubjectsCompletedPhase 1Boehringer IngelheimNCT02170805Written as BIBR 1048 MS capsule formulation A
As the comparator · 6 — what is tested is compared with Dabigatran
- Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical TherapyCompletedPhase 4Charite University, Berlin, GermanyNCT03463317Written as Dabigatran
- A Single Dose Bioequivalence Study of WD-1602 Versus Pradaxa® in Healthy Subjects Under Fed ConditionStatus unknownPhase 1Hong Kong WD Pharmaceutical Co., LimitedNCT04592822Written as Pradaxa®
- Clinical Trial to Assess the Safety and Pharmacokinetics of RDG-17012 Capsule and Pradaxa® Capsule in Healthy Male VolunteersStatus unknownPhase 1Huons Co., Ltd.NCT03495739Written as Dabigatran Etexilate Mesylate 150 MG Oral Capsule
- Bioavailability Study of Five Tablet Formulations of Dabigatran Etexilate Compared to Commercial Capsule Formulation in Healthy Male SubjectsCompletedPhase 1Boehringer IngelheimNCT02710630Written as Dabigatran etexilate capsule
- The Efficacy and Safety Study of Dabigatran and Warfarin to Non-valvular Atrial Fibrillation PatientsStatus unknownPhase 4The First Affiliated Hospital with Nanjing Medical UniversityNCT02646267Written as dabigatran etexilate
- Metabolism and Pharmacokinetics of [14C]-BIBR 953 ZW After Administration of Single Doses of [14C]-BIBR 953 ZW Intravenously or [14C]-BIBR 1048 Oral Solution in Healthy Male VolunteersCompletedPhase 1Boehringer IngelheimNCT02171442Written as BIBR 1048 Oral Solution
Codes
What other systems call Dabigatran · ClinicalTrials.gg INT006619
- MeSH (NLM) D000069604DabigatranConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) I0VM4M70GCDABIGATRANConfirmed FDA, NLM, Wikidata
- RxNorm 1546356Confirmed FDA, Wikidata
- Wikidata Q419345dabigatranConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C73224DabigatranOne source FDA
- DrugBank DB14726One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069604 | Dabigatran | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | I0VM4M70GC | DABIGATRAN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1546356 | — | Confirmed FDA, Wikidata |
| Wikidata | Q419345 | dabigatran | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C73224 | Dabigatran | One source FDA |
| DrugBank | DB14726 | — | One source Wikidata |
Also registered as dabigatran etexilate (UNII 2E18WX195X · RxNorm 1037042) and dabigatran etexilate mesylate (UNII SC7NUW5IIT · RxNorm 1037041).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.